Your browser doesn't support javascript.
loading
An Agonistic Antibody to EPHA2 Exhibits Antitumor Effects on Human Melanoma Cells.
Sakamoto, Atsushi; Kato, Kazunori; Hasegawa, Toshio; Ikeda, Shigaku.
Affiliation
  • Sakamoto A; Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Kato K; Atopy Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan kzkatou@juntendo.ac.jp.
  • Hasegawa T; Department of Biomedical Engineering, Toyo University, Saitama, Japan.
  • Ikeda S; Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Anticancer Res ; 38(6): 3273-3282, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29848674
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Movement / Receptor, EphA2 / Cell Proliferation / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: Anticancer Res Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Movement / Receptor, EphA2 / Cell Proliferation / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: Anticancer Res Year: 2018 Document type: Article Affiliation country: Country of publication: